IMPORTANT: Please refer to the package insert for complete instructions, contraindications, warnings and precautions.
A previously healthy 30-year-old male presented to an outpatient clinic with a two-week history of left-sided facial numbness. Magnetic resonance imaging (MRI) of the brain showed a densely enhancing mass measuring 4.4 Â 1.6 Â 2.0 cm (anteroposterior (AP) by transverse long axis (TR) by craniocaudal (CC)), with extension from the cerebellopontine angle into Meckel's cave along the left trigeminal nerve (Figure 1 (a)-(c)). He returned two months later with new-onset diplopia and inability to abduct the left eye. Clinical exam was significant for atrophy of the left masseter and temporalis muscles, suggestive of involvement of the third division of the left trigeminal nerve. Follow-up MRI showed increased size of the mass, now measuring 5.1 Â 2.6 Â 3.1 cm (AP by TR by CC) (Figure 1 (e), (f)). His computed tomography (CT) demonstrated erosive changes of the posterior sphenoid body (Figure 1(d) ).
The escalation of symptoms prompted the decision toward surgical management. Intratumoral debulking was performed with incision of the tumor capsule followed by suction and bipolar electrocautery. The initial postoperative diagnosis was a 'small blue cell tumor' of trigeminal origin. Immunohistochemistry (IHC) staining was negative for integrase interactor 1 (INI-1), which was consistent with atypical teratoid/rhabdoid tumor (AT/RT) ( Figure 2 ). The patient did well postoperatively and was started on outpatient chemotherapy and radiation.
Discussion
AT/RTs are highly malignant tumors (World Health Organization (WHO) grade IV) that most often occur in children under three years of age, accounting for 1%-2% of brain tumors in this age group. A slight male predominance has been reported. Rarely, these lesions may arise in adults. 1 The overwhelming majority of cases occur sporadically, although a rare genetic form has been documented. 2 Arriving at the correct diagnosis with imaging can be challenging, especially when the tumor occurs in an atypical demographic or location. Approximately half present as an intra-axial posterior fossa mass. 3 Compared to medulloblastomas, AT/RTs more frequently arise off-midline and involve the cerebellopontine angle (CPA). In the few reported cases of cranial nerve AT/RT, the sixth and seventh cranial nerves were most frequently involved. 4 To our knowledge, cases of AT/RT involving the trigeminal nerve have not been documented in adults. On CT, the mass is usually isoor hyperdense relative to normal brain parenchyma. Bone window CT may show osseous destruction if the lesion is situated near the skull base or inner table of the calvarium. 5 Intratumoral calcifications may also be seen.
On MRI, T1-weighted images show a mass that is iso-to hyperintense to normal gray matter. T1-hyperintense foci may be seen, likely representing intratumoral hemorrhage. On T2-weighted sequences, the 
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Contrast enhancement is expected and often heterogeneous. 1 Diffusion restriction is usually present, reflecting the hypercellular nature of the lesion. 6 However, peritumoral edema is relatively mild compared to other high-grade tumors. On MR spectroscopy, there is decreased N-acetylasparatate and creatinine, as well as increased choline. MRI of the entire neuroaxis is recommended to assess for drop metastases and leptomeningeal spread. If follow-up imaging is obtained, rapid growth may be observed. Diagnosis based on histological criteria can be difficult, which may be attributed to the heterogeneity in the constituent cell types. Although rhabdoid tumor cells are characteristic for AT/RT, they may be present in only a small portion of the mass, leading to misdiagnosis as a primitive neuroectodermal tumor (PNET) or medulloblastoma. By comparison, molecular testing offers greater clinical utility. Loss of expression/function of the INI1 protein (which forms part of the switch/sucrose nonfermentable (SWI/SNF) chromatinremodeling complex) is considered diagnostic for AT/ RT. 7, 8 This may be assessed through IHC staining for the INI1 protein.
Because of its rarity, there is currently no standard of care for managing adult AT/RTs. 4 In most cases, treatment is based on the approach taken for children, which primarily involves maximal tumor resection. This is usually followed by adjuvant chemotherapy. In a review of 28 adult AT/RT cases, temozolamide and ifosphamide, carboplatin, and etoposide (ICE) chemotherapy were commonly used regimens. 2 Radiation is often incorporated as part of adjuvant therapy except in children under the age of two years to avoid long-term neurocognitive detriment.
In conclusion, AT/RT with trigeminal nerve involvement can present a management dilemma in adults. Awareness of this entity and its imaging characteristics, such as diffusion restriction, cystic and hemorrhagic change, and osseous erosion, may lead the radiologist to first raise the possibility of the diagnosis. This may prompt confirmatory diagnostic testing and expedite appropriate therapies for this highly aggressive neoplasm.
